HL-1 Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | HL-1 is a cardiac muscle cell line derived from the atrial cardiomyocytes of an adult mouse. This cell line is unique in that it retains the ability to contract and maintain a differentiated cardiac phenotype over long-term culture, making it an invaluable model for cardiovascular research. HL-1 cells are widely used in studies focused on cardiac physiology, electrophysiology, and pharmacology. Their ability to undergo spontaneous and inducible contractions allows researchers to investigate the molecular mechanisms underlying cardiac muscle function, disease, and response to therapeutic agents. HL-1 cells exhibit characteristics typical of cardiac muscle cells, including the expression of cardiac-specific markers such as troponin, myosin, and connexin 43. They are responsive to various physiological and pharmacological stimuli, enabling detailed studies of cardiac signal transduction pathways, ion channel function, and the effects of drugs on heart cells. This cell line is particularly valuable for modeling cardiac arrhythmias, hypertrophy, and other cardiac pathologies. Additionally, HL-1 cells are used in high-throughput drug screening assays aimed at identifying compounds that modulate cardiac function, which is crucial for the development of new treatments for cardiovascular diseases. |
|---|---|
| Organism | Mouse |
| Tissue | Heart, left atrium |
| Disease | Normal atrial cardiomyocyte (SV40 large T antigen-immortalized via AT-1 lineage; spontaneously contracting; non-tumorigenic in standard use) |
| Applications | Cardiac physiology and electrophysiology; cardiomyocyte biology; cardiac arrhythmia modeling; ion channel function (IKr, INa, ICaL); cardiac hypertrophy and remodeling; cardiac ischemia/reperfusion injury; drug cardiotoxicity screening; connexin43 and gap junction biology; atrial-specific gene expression (ANF, α-MHC, α-actin); spontaneous contractility assays; high-throughput cardiac drug screening; multi-electrode array (MEA) electrophysiology |
| Synonyms | HL1, HL-1 F2 P76 |
Characteristics
| Breed/Subspecies | C3HeB/FeJ transgenic |
|---|---|
| Age | Unspecified |
| Gender | Female |
| Ethnicity | Not applicable (C3HeB/FeJ transgenic mouse strain; breed in Q) |
| Morphology | Cardiomyocyte-like |
| Cell type | Cardiomyocyte |
| Growth properties | Adherent |
Regulatory Data
| Citation | HL-1 (Cytion catalog number 305264) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_0303 |
Biomolecular Data
| Viruses | Transformant: Simian virus 40 (SV40) |
|---|
Handling
| Culture Medium | Claycomb medium, 2 mM glutamine, 10% FBS, 0.1 mM norepinephrine in L-ascorbic acid (We do not sell) Prepare 0.1 mM norepinephrine in L-ascorbic acid: Prepare a 100-fold stock solution = 10 mM norepinephrine. 1. Prepare a 30 mM L-ascorbic acid solution (50 mL) 2. Add 160 mg of norepinephrine to the ascorbic acid solution (50 mL) = 10 mM norepinephrine 3. Sterilely filter the solution through a 0.2-µm filter cartridge. 4. Fill 1-mL aliquots of the 100-fold norepinephrine stock solution into sterile vials and store at −20 °C. Wrap in aluminum foil; must be protected from light. The solution is stable for approximately 1 month at −20 °C. 5. Add 1 mL of this solution to 100 mL of Claycomb medium. The medium is stable for only 1 month. |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 2 mM glutamine, 0.1 mM norepinephrine in L-ascorbic acid |
| Dissociation Reagent | Accutase |
| Doubling time | approx. 24 to 36 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Split ratio | 1 to 3 |
| Seeding density | 2 to 4 x 104 cells/cm2 |
| Fluid renewal | Daily (Claycomb Medium changed every 24 hours to maintain contractile phenotype) |
| Post-Thaw Recovery | After thawing, plate cells onto fibronectin/gelatin-coated flasks (pre-coat with 12.5 µg/ml fibronectin and 0.02% gelatin; incubate 37°C for ≥1 hour, aspirate before seeding). Allow 24–48 hours for adherence and recovery before the first medium change. Feed daily with supplemented Claycomb Medium thereafter. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Flask Coating | The cell culture bottles must be coated with fibronectin and gelatin. 25 µg fibronectin, dissolved in 2 ml of 0.02% gelatin in water, are placed in a T25 and incubated overnight at 37°C |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305264-180526 | Certificate of Analysis | 24. Jun. 2026 | 305264 |